Esoteric Testing Market size was valued at USD 26.01 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 12% through 2024 to 2030, reaching nearly USD 56.44 Bn. Esoteric research allows for the study of uncommon compounds or molecules that aren't normally tested in a clinical lab. Reference and esoteric research laboratories are used by many major commercial labs to outsource complex experiments. However, as laboratory testing technology advances, tests that are currently considered esoteric may become commonplace in just a few years. This is frequently the product of dedicated research and development efforts. These tests are ordered when a doctor needs more details than normal lab testing to complete a diagnosis, determine a prognosis, or select and track a therapeutic regimen. Esoteric research usually necessitates the use of advanced instruments and materials, as well as trained staff to conduct and evaluate the tests. Since it is not cost-efficient for hospitals and physician office laboratories to conduct the tests in-house, they are usually outsourced to separate, specialist clinical reference laboratories.To know about the Research Methodology:- Request Free Sample Report
Global Esoteric Testing Market Dynamics:
Rising demand for early and accurate disease diagnosis With the improving the accuracy of medical diagnosis with causal machine learning and increasing prevalence of infectious diseases supporting the market growth. Global healthcare services face a fundamental challenge in providing a reliable and affordable diagnosis. Every year, an estimated 5% of outpatients in the United States obtain the incorrect diagnosis. When diagnosing patients with serious medical conditions, these errors are especially common, with an estimated 20% of these patients being misdiagnosed at the primary care level. 3 and 1 in 3 of these misdiagnoses result in significant harm to the patient. The public-private investments, as well as research funding and grants to improve novel laboratory testing methods, and advances in clinical diagnostic techniques, are all driving market development. The key factors driving the increased use of genomics and proteomics, as well as the increased use of molecular diagnostics, are patient knowledge of the benefits of these technologies. Esoteric studies, which include the study of "rare" molecules or substances, are an important part of many chronic diseases and disorder treatment regimens. However, these tests are ordered less frequently than routine tests and are generally priced higher than the routine tests which restrain the market growth. The report has profiled twenty-five key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. The manufacturing environment in each region is different and focus is given on the regional impact on the cost of manufacturing, supply chain, availability of raw materials, labour cost, availability of advanced technology, trusted vendors are analysis and report has come up with recommendations for a future hot spot in North America.Global Esoteric Testing Market Segment Analysis
The infectious diseases testing segment is expected to grow at a CAGR of xx% during the forecast period. Based on the type, in 2021, the infectious diseases testing segment holds the largest market share of xx% 2021 and it is estimated to reach USD$ xx Mn by 2029. The rising incidence/prevalence of target diseases (chronic, infectious, and lifestyle-related diseases), the acceptance of advanced technologies, and the healthcare expenditure across the globe are all contributing to this segment's large share. The Indian healthcare sector is expected to reach US$ 193.83 billion by 2021. Rising income level, greater health awareness, increased precedence of lifestyle diseases and improved access to insurance would be the key contributors to growth. Health insurance is gaining momentum in India. Gross direct premium income underwritten by health insurance grew 17.16% y-o-y to Rs. 51,637.84 crore (US$ 7.39 billion) in the year 2021.Regional Insights:
Asia-Pacific to witness a high market growth rate and is expected to grow at a CAGR of xx% by 2029 The Asia Pacific market for Esoteric Testing is expected to rise at a faster pace than the rest of the world by 2029. In the Asia-Pacific region, China and India are projected to rise at the fastest rates in terms of revenue. Developing economies like China, India, Russia, Turkey, South Korea, Brazil, and South Africa are investing more in the healthcare department besides government favorable policies are fueling the market growth. As a result majority of players operating in this market are targeting these regions. In addition, improving healthcare infrastructure, high disease prevalence, large patient population and growing medical tourism in these countries are driving the market growth. In these countries, the prevalence of chronic diseases such as cancer has risen dramatically. According to WHO Africa, Asia, Central and South America account for more than 60% of all new cancer cases each year. Furthermore, esoteric research service providers would be compelled to concentrate on emerging markets due to increased competition in mature markets. The objective of the report is to present a comprehensive analysis of the global Esoteric Testing market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global Esoteric Testing market dynamics, structure by analyzing the market segments and project the global Esoteric Testing market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Esoteric Testing market make the report investor’s guide.Esoteric Testing Market Recent Developments:
In 2021, LabCorp launched ADAMTS13 test to distinguish diseases characterized by life-threatening, acute thrombotic microangiopathy (TMA), including most significantly thrombotic thrombocytopenia purpura (TTP). In 2021, Myriad Genetics, Inc. launched the EndoPredict test in the US for patients with ER+ HER2- early-stage breast cancer. This test launch will strengthen the company’s oncology product portfolio and represents an advancement in the treatment of patients with breast cancer. In 2021, Bristol-Myers Squibb Company and Foundation Medicine collaborated to leverage Foundation Medicine's comprehensive genomic profiling and molecular information solutions to identify predictive biomarkers such as Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) in patients.Esoteric Testing Market Covid-19 Impact:
COVID-19 Impact on the global Esoteric Testing market As the number of Covid-19 infections rises around the world, fears of a shortage of life-saving equipment and other critical medical supplies to stop the pandemic from spreading and provide the best possible treatment to those who have been infected grow. Furthermore, before pharmacological treatment is established, ventilators are an important treatment option for COVID-19 patients who may need critical care. Furthermore, there is a pressing need to speed up the production process for a wide variety of test kits (antibody tests, self-administered, and others). Covid19 will be accounted for as a significant market contributor in the study.Esoteric Testing Industry
Global Esoteric Testing Market Scope: Inquire before buying
Global Esoteric Testing Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 26.01 Bn. Forecast Period 2024 to 2030 CAGR: 12% Market Size in 20230: USD 56.44 Bn. Segments Covered: by Type Infectious Diseases Testing Endocrinology Testing Oncology testing Immunology Testing Genetic Testing Toxicology Testing Neurology Testing Others by Technology Chemiluminescence Immunoassay (CLIA) Enzyme-linked Immunosorbent Assay (ELISA) Mass Spectrometry Real Time - PCR Flow Cytometry Radioimmunoassay Others by Laboratory Type Independent & Reference Laboratories Hospital Laboratories Global Esoteric Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)Key Players
1.LabCorp 2.Quest Diagnostics 3.OPKO Health 4.Miraca Holdings 5.ARUP Laboratories 6.Myriad Genetics 7.Genomic Health 8.American Medical Laboratories 9.Foundation Medicines 10.Mayo Medical Laboratories 11.Primary Healthcare 12.Healthscope 13.Sonic Healthcare 14.Fulgent Genetics 15.Spectra Laboratories 16.Nordic Lifesciences 17.InVitae 18.Unilabs 19.SYNLAB 20.Other key playersFrequently Asked Questions:
1. Which region has the largest share in Global Esoteric Testing Market? Ans: Asia Pacific region held the highest share in 2023. 2. What is the growth rate of Global Esoteric Testing Market? Ans: The Global is growing at a CAGR of 12% during forecasting period 2024-2030. 3. What is scope of the Global Esoteric Testing Market report? Ans: Global Esoteric Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this Market? Ans: The Global Esoteric Testing Market is studied from 2018 to 2023.
1. Global Esoteric Testing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Esoteric Testing Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Company Location 2.3.3. Product Segment 2.3.4. End-user Segment 2.3.5. Revenue (2023) 2.3.6. Growth Rate (Y-O-Y in %) 2.3.7. Key Development 2.3.8. Market Share 2.4. Industry Ecosystem Analysis 2.4.1. Supply Side 2.4.2. Demand Side 2.4.3. Trends/Disruption impacting customer business 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Consolidation of the Market 2.6.1. Strategic Initiatives and Developments 2.6.2. Mergers and Acquisitions 2.6.3. Collaborations and Partnerships 2.6.4. Product Launches and Innovations 3. Global Esoteric Testing Market: Dynamics 3.1. Esoteric Testing Market Trends 3.2. Esoteric Testing Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. PESTLE Analysis 3.5. Value Chain Analysis 3.6. Trade Analysis 3.7. Technology Analysis 3.7.1. Key Technology 3.7.1.1. Immunoassay techniques 3.7.2. Complementary Technologies 3.7.2.1. Polymerase chain reaction 3.7.3. Adjacent Technologies 3.7.3.1. Mass spectrometry 3.7.3.2. Flow cytometry 3.8. Regulatory Landscape 3.8.1. Regulations by Country 3.8.1.1. US 3.8.1.2. Canada 3.8.1.3. Japan 3.8.1.4. India 3.8.1.5. China 3.8.1.6. Saudi Arabia 3.8.1.7. UAE 3.8.2. Regulatory Bodies, Government Agencies, and Other Organizations 3.9. Pricing Analysis 4. Global Esoteric Testing Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. Global Esoteric Testing Market Size and Forecast, by Type (2023-2030) 4.1.1. Infectious Diseases Testing 4.1.2. Endocrinology Testing 4.1.3. Oncology testing 4.1.4. Immunology Testing 4.1.5. Genetic Testing 4.1.6. Toxicology Testing 4.1.7. Neurology Testing 4.1.8. Others 4.2. Global Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 4.2.1. Chemiluminescence Immunoassay (CLIA) 4.2.2. Enzyme-linked Immunosorbent Assay (ELISA) 4.2.3. Mass Spectrometry 4.2.4. Real Time - PCR 4.2.5. Flow Cytometry 4.2.6. Radioimmunoassay 4.2.7. Others 4.3. Global Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 4.3.1. Independent & Reference Laboratories 4.3.2. Hospital Laboratories 4.4. Global Esoteric Testing Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Esoteric Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. North America Esoteric Testing Market Size and Forecast, by Type (2023-2030) 5.1.1. Infectious Diseases Testing 5.1.2. Endocrinology Testing 5.1.3. Oncology testing 5.1.4. Immunology Testing 5.1.5. Genetic Testing 5.1.6. Toxicology Testing 5.1.7. Neurology Testing 5.1.8. Others 5.2. North America Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 5.2.1. Chemiluminescence Immunoassay (CLIA) 5.2.2. Enzyme-linked Immunosorbent Assay (ELISA) 5.2.3. Mass Spectrometry 5.2.4. Real Time - PCR 5.2.5. Flow Cytometry 5.2.6. Radioimmunoassay 5.2.7. Others 5.3. North America Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 5.3.1. Independent & Reference Laboratories 5.3.2. Hospital Laboratories 5.4. North America Esoteric Testing Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Esoteric Testing Market Size and Forecast, by Type (2023-2030) 5.4.1.1.1. Infectious Diseases Testing 5.4.1.1.2. Endocrinology Testing 5.4.1.1.3. Oncology testing 5.4.1.1.4. Immunology Testing 5.4.1.1.5. Genetic Testing 5.4.1.1.6. Toxicology Testing 5.4.1.1.7. Neurology Testing 5.4.1.1.8. Others 5.4.1.2. United States Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 5.4.1.2.1. Chemiluminescence Immunoassay (CLIA) 5.4.1.2.2. Enzyme-linked Immunosorbent Assay (ELISA) 5.4.1.2.3. Mass Spectrometry 5.4.1.2.4. Real Time - PCR 5.4.1.2.5. Flow Cytometry 5.4.1.2.6. Radioimmunoassay 5.4.1.2.7. Others 5.4.1.3. United States Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 5.4.1.3.1. Independent & Reference Laboratories 5.4.1.3.2. Hospital Laboratories 5.4.2. Canada 5.4.2.1. Canada Esoteric Testing Market Size and Forecast, by Type (2023-2030) 5.4.2.1.1. Infectious Diseases Testing 5.4.2.1.2. Endocrinology Testing 5.4.2.1.3. Oncology testing 5.4.2.1.4. Immunology Testing 5.4.2.1.5. Genetic Testing 5.4.2.1.6. Toxicology Testing 5.4.2.1.7. Neurology Testing 5.4.2.1.8. Others 5.4.2.2. Canada Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 5.4.2.2.1. Chemiluminescence Immunoassay (CLIA) 5.4.2.2.2. Enzyme-linked Immunosorbent Assay (ELISA) 5.4.2.2.3. Mass Spectrometry 5.4.2.2.4. Real Time - PCR 5.4.2.2.5. Flow Cytometry 5.4.2.2.6. Radioimmunoassay 5.4.2.2.7. Others 5.4.2.3. Canada Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 5.4.2.3.1. Independent & Reference Laboratories 5.4.2.3.2. Hospital Laboratories 5.4.3. Mexico 5.4.3.1. Mexico Esoteric Testing Market Size and Forecast, by Type (2023-2030) 5.4.3.1.1. Infectious Diseases Testing 5.4.3.1.2. Endocrinology Testing 5.4.3.1.3. Oncology testing 5.4.3.1.4. Immunology Testing 5.4.3.1.5. Genetic Testing 5.4.3.1.6. Toxicology Testing 5.4.3.1.7. Neurology Testing 5.4.3.1.8. Others 5.4.3.2. Mexico Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 5.4.3.2.1. Chemiluminescence Immunoassay (CLIA) 5.4.3.2.2. Enzyme-linked Immunosorbent Assay (ELISA) 5.4.3.2.3. Mass Spectrometry 5.4.3.2.4. Real Time - PCR 5.4.3.2.5. Flow Cytometry 5.4.3.2.6. Radioimmunoassay 5.4.3.2.7. Others 5.4.3.3. Mexico Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 5.4.3.3.1. Independent & Reference Laboratories 5.4.3.3.2. Hospital Laboratories 6. Europe Esoteric Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Europe Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.2. Europe Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.3. Europe Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 6.4. Europe Esoteric Testing Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.4.1.2. United Kingdom Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.4.1.3. United Kingdom Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 6.4.2. France 6.4.2.1. France Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.4.2.2. France Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.4.2.3. France Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.4.3.2. Germany Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.4.3.3. Germany Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.4.4.2. Italy Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.4.4.3. Italy Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.4.5.2. Spain Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.4.5.3. Spain Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.4.6.2. Sweden Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.4.6.3. Sweden Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 6.4.7. Russia 6.4.7.1. Russia Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.4.7.2. Russia Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.4.7.3. Russia Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Esoteric Testing Market Size and Forecast, by Type (2023-2030) 6.4.8.2. Rest of Europe Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 6.4.8.3. Rest of Europe Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 7. Asia Pacific Esoteric Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Esoteric Testing Market Size and Forecast, by Type (2023-2030) 7.2. Asia Pacific Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 7.3. Asia Pacific Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 7.4. Asia Pacific Esoteric Testing Market Size and Forecast, by Industry (2023-2030) 7.5. Asia Pacific Esoteric Testing Market Size and Forecast, by Country (2023-2030) 7.5.1. China 7.5.1.1. China Esoteric Testing Market Size and Forecast, by Type (2023-2030) 7.5.1.2. China Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 7.5.1.3. China Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 7.5.2. S Korea 7.5.2.1. S Korea Esoteric Testing Market Size and Forecast, by Type (2023-2030) 7.5.2.2. S Korea Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 7.5.2.3. S Korea Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 7.5.3. Japan 7.5.3.1. Japan Esoteric Testing Market Size and Forecast, by Type (2023-2030) 7.5.3.2. Japan Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 7.5.3.3. Japan Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 7.5.4. India 7.5.4.1. India Esoteric Testing Market Size and Forecast, by Type (2023-2030) 7.5.4.2. India Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 7.5.4.3. India Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 7.5.5. Australia 7.5.5.1. Australia Esoteric Testing Market Size and Forecast, by Type (2023-2030) 7.5.5.2. Australia Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 7.5.5.3. Australia Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 7.5.6. ASEAN 7.5.6.1. ASEAN Esoteric Testing Market Size and Forecast, by Type (2023-2030) 7.5.6.2. ASEAN Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 7.5.6.3. ASEAN Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 7.5.7. Rest of Asia Pacific 7.5.7.1. Rest of Asia Pacific Esoteric Testing Market Size and Forecast, by Type (2023-2030) 7.5.7.2. Rest of Asia Pacific Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 7.5.7.3. Rest of Asia Pacific Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 8. Middle East and Africa Esoteric Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 8.1. Middle East and Africa Esoteric Testing Market Size and Forecast, by Type (2023-2030) 8.2. Middle East and Africa Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 8.3. Middle East and Africa Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 8.4. Middle East and Africa Esoteric Testing Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Esoteric Testing Market Size and Forecast, by Type (2023-2030) 8.4.1.2. South Africa Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 8.4.1.3. South Africa Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Esoteric Testing Market Size and Forecast, by Type (2023-2030) 8.4.2.2. GCC Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 8.4.2.3. GCC Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 8.4.3. Rest of MEandA 8.4.3.1. Rest of MEandA Esoteric Testing Market Size and Forecast, by Type (2023-2030) 8.4.3.2. Rest of MEandA Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 8.4.3.3. Rest of MEandA Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 9. South America Esoteric Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 9.1. South America Esoteric Testing Market Size and Forecast, by Type (2023-2030) 9.2. South America Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 9.3. South America Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 9.4. South America Esoteric Testing Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Esoteric Testing Market Size and Forecast, by Type (2023-2030) 9.4.1.2. Brazil Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 9.4.1.3. Brazil Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Esoteric Testing Market Size and Forecast, by Type (2023-2030) 9.4.2.2. Argentina Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 9.4.2.3. Argentina Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 9.4.3. Rest of South America 9.4.3.1. Rest of South America Esoteric Testing Market Size and Forecast, by Type (2023-2030) 9.4.3.2. Rest of South America Esoteric Testing Market Size and Forecast, by Technology (2023-2030) 9.4.3.3. Rest of South America Esoteric Testing Market Size and Forecast, by Laboratory Type (2023-2030) 10. Company Profile: Key Players 10.1. LabCorp 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Quest Diagnostics 10.3. OPKO Health 10.4. Miraca Holdings 10.5. ARUP Laboratories 10.6. Myriad Genetics 10.7. Genomic Health 10.8. American Medical Laboratories 10.9. Foundation Medicines 10.10. Mayo Medical Laboratories 10.11. Primary Healthcare 10.12. Healthscope 10.13. Sonic Healthcare 10.14. Fulgent Genetics 10.15. Spectra Laboratories 10.16. Nordic Lifesciences 10.17. InVitae 10.18. Unilabs 10.19. SYNLAB 10.20. Other key players 11. Key Findings & Analyst Recommendations 12. Esoteric Testing Market: Research Methodology 12.1. Top-Down Approach 12.2. Bottom-up Approach 12.3. Market Breakdown and Data Triangulation 12.4. Research Assumption
